Tumor Reduction with Pazopanib in a Patient with Recurrent Lumbar Chordoma
Introduction. Chordomas are rare malignancies of bone origin that occur in the axial skeleton, typically the skull base and lumbar/sacral regions. Although often classified as low-grade neoplasms, its locally infiltrative behavior may result in significant morbidity and mortality. Optimal surgical r...
Saved in:
Main Authors: | Maurício Fernando Silva Almeida Ribeiro, Micelange Carvalho de Sousa, Samir Abdallah Hanna, Marcos Vinicius Calfat Maldaun, Ceci Obara Kurimori, Luiz Guilherme Cernaglia Aureliano de Lima, Romulo Loss Mattedi, Rodrigo Ramella Munhoz |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | Case Reports in Oncological Medicine |
Online Access: | http://dx.doi.org/10.1155/2018/4290131 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Advanced Alveolar Soft Part Sarcoma Treated with Pazopanib over Three Years
by: Yoji Shido, et al.
Published: (2017-01-01) -
Combined Therapy for Distant Metastasis of Sacral Chordoma
by: Birol Özkal, et al.
Published: (2015-01-01) -
Chondroid Chordoma and Nasal Adenocarcinoma: An Exceptional Association
by: Patrice Gallet, et al.
Published: (2012-01-01) -
Chordoma Spontaneous Regression After COVID-19
by: Luis Fernando Moura da Silva Junior, et al.
Published: (2024-12-01) -
Clinical Outcome of Third-Line Pazopanib in a Patient with Metastatic Renal Cell Carcinoma
by: Michela Roberto, et al.
Published: (2015-01-01)